NCT02046174View on ClinicalTrials.gov

Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared to Best Supportive Care in Colorectal Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 3, 2014

Primary Completion Date

October 22, 2018

Study Completion Date

October 22, 2018

Conditions
Colorectal Cancers
Interventions
BIOLOGICAL

RENCA macrobeads

Trial Locations (4)

10021

Weill Cornell Medical Center / The Rogosin Institute, New York

10461

Calvary Hospital, The Bronx

66205

University of Kansas Cancer Center, Westwood

43210-1228

The Ohio State University; OSU Comprehensive Cancer Center, Columbus

All Listed Sponsors
collaborator

Vital Systems Inc.

OTHER

lead

The Rogosin Institute

OTHER

NCT02046174 - Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared to Best Supportive Care in Colorectal Cancer Patients | Biotech Hunter | Biotech Hunter